In response to my article about commercial funding of nonprofit organizations from the manufacturers of the PCSK9 inhibitors, Joshua Knowles wrote an eloquent and heartfelt defense of the FH Foundation, which receives some funding from industry. But I think he fails to address the fundamental underlying issues I wrote about in my piece. Knowles writes that “FH is a…
Praising The Virtues Of The Familial Hypercholesterolemia Foundation
October 16, 2015 by Leave a Comment
The following letter was sent by Joshua Knowles in response to a previous post, Desperately Seeking Patients: New Cholesterol Drug Makers Fuel Research To Find Customers. Dr. Knowles is a faculty member and clinician at Stanford University who specializes in familial hypercholesterolemia. He is also the chief medical advisor for the FH Foundation. Dear Mr. Husten, I…
Recent Comments